company background image
6826 logo

Shanghai Haohai Biological Technology SEHK:6826 株式レポート

最終価格

HK$29.25

時価総額

HK$14.3b

7D

-9.2%

1Y

29.6%

更新

24 Jun, 2024

データ

会社財務

Shanghai Haohai Biological Technology Co., Ltd.

SEHK:6826 株式レポート

時価総額:HK$14.3b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

6826 株式概要

上海昊海生物技術有限公司

6826 ファンダメンタル分析
スノーフレーク・スコア
評価4/6
将来の成長0/6
過去の実績4/6
財務の健全性5/6
配当金2/6

Shanghai Haohai Biological Technology Co., Ltd. 競合他社

価格と性能

の歴代最高値、変動、値下がりまとめShanghai Haohai Biological Technology
過去の株価
現在の株価HK$29.25
52週高値HK$35.86
52週安値HK$21.71
ベータ0.77
11ヶ月の変化-1.09%
3ヶ月変化4.60%
1年変化29.59%
33年間の変化-58.97%
5年間の変化-3.87%
IPOからの変化-29.88%

最新ニュース

Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All

May 22
Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All

Recent updates

Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All

May 22
Why We Think Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) CEO Compensation Is Not Excessive At All

Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly

Apr 17
Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly

Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?

Feb 12
Are Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Paying Above The Intrinsic Value?

Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?

Nov 14
Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?

Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet

Jul 28
Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet

We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt

Mar 09
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt

These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well

Nov 25
These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well

Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet

Jul 30
Shanghai Haohai Biological Technology (HKG:6826) Has A Pretty Healthy Balance Sheet

Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price

May 08
Shanghai Haohai Biological Technology Co., Ltd.'s (HKG:6826) Intrinsic Value Is Potentially 96% Above Its Share Price

Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?

Apr 19
Is Shanghai Haohai Biological Technology (HKG:6826) Using Too Much Debt?

Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)

Mar 04
Analyst Forecasts Just Became More Bearish On Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)

Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Mar 03
Shanghai Haohai Biological Technology Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models

Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?

Jan 10
Is Shanghai Haohai Biological Technology (HKG:6826) A Risky Investment?

Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly

Oct 08
Shanghai Haohai Biological Technology (HKG:6826) Seems To Use Debt Rather Sparingly

Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly

Jul 07
Here's Why Shanghai Haohai Biological Technology (HKG:6826) Can Manage Its Debt Responsibly

Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%

May 27
Analysts Have Just Cut Their Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Revenue Estimates By 14%

These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well

Apr 04
These 4 Measures Indicate That Shanghai Haohai Biological Technology (HKG:6826) Is Using Debt Reasonably Well

Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%

Mar 16
Investors Who Bought Shanghai Haohai Biological Technology (HKG:6826) Shares A Year Ago Are Now Up 58%

Can Mixed Fundamentals Have A Negative Impact on Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Current Share Price Momentum?

Feb 23
Can Mixed Fundamentals Have A Negative Impact on Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Current Share Price Momentum?

What Type Of Shareholders Own The Most Number of Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Shares?

Feb 05
What Type Of Shareholders Own The Most Number of Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Shares?

Does Shanghai Haohai Biological Technology's (HKG:6826) Statutory Profit Adequately Reflect Its Underlying Profit?

Jan 21
Does Shanghai Haohai Biological Technology's (HKG:6826) Statutory Profit Adequately Reflect Its Underlying Profit?

Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Should Think About This Before Buying It For Its Dividend

Jan 06
Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826) Investors Should Think About This Before Buying It For Its Dividend

We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt

Dec 22
We Think Shanghai Haohai Biological Technology (HKG:6826) Can Stay On Top Of Its Debt

株主還元

6826HK BiotechsHK 市場
7D-9.2%-2.5%0.6%
1Y29.6%-33.0%2.4%

業界別リターン: 6826過去 1 年間で-35.7 % の収益を上げたHong Kong Biotechs業界を上回りました。

リターン対市場: 6826過去 1 年間で-1.8 % の収益を上げたHong Kong市場を上回りました。

価格変動

Is 6826's price volatile compared to industry and market?
6826 volatility
6826 Average Weekly Movement4.2%
Biotechs Industry Average Movement9.0%
Market Average Movement7.2%
10% most volatile stocks in HK Market15.1%
10% least volatile stocks in HK Market3.7%

安定した株価: 6826過去 3 か月間に大きな価格変動はありませんでした。

時間の経過による変動: 6826の 週次ボラティリティ ( 4% ) は過去 1 年間安定しています。

会社概要

設立従業員CEO(最高経営責任者ウェブサイト
20072,158Jianying Wuwww.3healthcare.com

上海昊海生物科技有限公司は、中国、欧州、米国、および国際的な生物医学材料の研究、開発、製造、販売に従事している。同社は眼内レンズ、医療用ヒアルロン酸ナトリウムゲル、潤滑点眼薬からなる眼科製品を提供している。また、ヒアルロン酸ナトリウム注射液、医療用キトサン、ヒアルロン酸ナトリウムゲル、ヒアルロン酸ナトリウムゲル、癒着防止剤、火傷創傷関連製品も提供している。さらに、注射器、メス、縫合針も提供している。さらに、注入用の単相ヒアルロン酸ナトリウムゲルである第一世代ヒアルロン酸(HA)皮膚フィラー「マトリフィル」、動的充填機能を持つ第二世代HA皮膚フィラー「ジャンレーン」、精密な装飾機能を提供する第三世代HA皮膚フィラー「ヒアルマトリックス」、表皮修復のための遺伝子工学製剤、高周波機器およびレーザー機器からなる医療美容製品を提供している。さらに、生物工学および医薬品の研究開発、関連技術移転、コンサルティング・サービスの提供、プロ用美容機器および家庭用美容機器の販売、生物学的試薬、生物学的材料、その他の機械および付属品の製造・販売にも携わっている。以前はHaohai Limitedとして知られていたが、2010年にShanghai Haohai Biological Technology Co.上海昊海生物技術有限公司は2007年に設立され、中国上海市に本社を置く。

Shanghai Haohai Biological Technology Co., Ltd. 基礎のまとめ

Shanghai Haohai Biological Technology の収益と売上を時価総額と比較するとどうか。
6826 基礎統計学
時価総額HK$14.26b
収益(TTM)HK$464.89m
売上高(TTM)HK$2.89b

14.8x

PER(株価収益率

2.4x

P/Sレシオ

収益と収入

最新の決算報告書(TTM)に基づく主な収益性統計
6826 損益計算書(TTM)
収益CN¥2.69b
売上原価CN¥821.59m
売上総利益CN¥1.87b
その他の費用CN¥1.43b
収益CN¥432.49m

直近の収益報告

Mar 31, 2024

次回決算日

該当なし

一株当たり利益(EPS)1.84
グロス・マージン69.44%
純利益率16.08%
有利子負債/自己資本比率6.4%

6826 の長期的なパフォーマンスは?

過去の実績と比較を見る

配当金

1.9%

現在の配当利回り

55%

配当性向